drugset / Trial / NCT00277069
Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
1\. Determine the response rate with this regimen in an anthracycline and taxane resistant cohort of patients.
Timeline
- Start
- 2000-05
- Primary completion
- 2005-03
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1500 mg/m2 | Oral |
| Subject | Carboplatin | Small molecule | 300 mg/m2 | Intravenous |
| Subject | Vinorelbine | Small molecule | 25 mg/m2 | Intravenous |